Literature DB >> 24803403

Perfluorooctanoate exposure and major birth defects.

Cheryl R Stein1, David A Savitz2, Beth Elston3, Phoebe G Thorpe4, Suzanne M Gilboa5.   

Abstract

Perfluorooctanoate (PFOA) is detectable in umbilical cord blood and amniotic fluid. Some toxicological findings suggest that perfluoroalkyl substances may be teratogenic. Using data from the C8 Health Project, a 2005-2006 survey in a Mid-Ohio Valley community exposed to PFOA through contaminated drinking water, we examined the association between estimated prenatal PFOA concentration and maternally reported birth defects (n=325) among 10,262 live singleton or multiple births from 1990 to 2006. Logistic regression models accounted for siblings using generalized estimating equations. There was generally no association between estimated PFOA concentration and birth defects, with the possible exception of brain defects, where the odds ratio adjusted for year of conception was 2.6 (95% confidence interval 1.3-5.1) for an increase in estimated PFOA exposure from the 25th to 75th percentile. This estimate, however, was based on 13 cases and may represent a chance finding. Further investigation of this potential association may be warranted.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital abnormalities; Epidemiology; Fluorocarbons; Perfluorooctanoic acid

Mesh:

Substances:

Year:  2014        PMID: 24803403      PMCID: PMC4117925          DOI: 10.1016/j.reprotox.2014.04.006

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  30 in total

1.  Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds.

Authors:  M T Case; R G York; M S Christian
Journal:  Int J Toxicol       Date:  2001 Mar-Apr       Impact factor: 2.032

2.  Effects of perfluorooctanoic acid exposure during pregnancy in the mouse.

Authors:  Christopher Lau; Julie R Thibodeaux; Roger G Hanson; Michael G Narotsky; John M Rogers; Andrew B Lindstrom; Mark J Strynar
Journal:  Toxicol Sci       Date:  2006-01-16       Impact factor: 4.849

3.  Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China.

Authors:  Man Ka So; Nobuyoshi Yamashita; Sachi Taniyasu; Qinting Jiang; John P Giesy; Kun Chen; Paul Kwan Sing Lam
Journal:  Environ Sci Technol       Date:  2006-05-01       Impact factor: 9.028

Review 4.  The developmental toxicity of perfluoroalkyl acids and their derivatives.

Authors:  Christopher Lau; John L Butenhoff; John M Rogers
Journal:  Toxicol Appl Pharmacol       Date:  2004-07-15       Impact factor: 4.219

5.  Perfluorinated compounds in human milk from Massachusetts, U.S.A.

Authors:  Lin Tao; Kurunthachalam Kannan; Chung M Wong; Kathleen F Arcaro; John L Butenhoff
Journal:  Environ Sci Technol       Date:  2008-04-15       Impact factor: 9.028

Review 6.  Perfluoroalkyl acids: a review of monitoring and toxicological findings.

Authors:  Christopher Lau; Katherine Anitole; Colette Hodes; David Lai; Andrea Pfahles-Hutchens; Jennifer Seed
Journal:  Toxicol Sci       Date:  2007-05-22       Impact factor: 4.849

7.  Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk.

Authors:  Zsuzsanna Kuklenyik; John Adam Reich; Jason S Tully; Larry L Needham; Antonia M Calafat
Journal:  Environ Sci Technol       Date:  2004-07-01       Impact factor: 9.028

8.  Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study.

Authors:  O Midasch; H Drexler; N Hart; M W Beckmann; J Angerer
Journal:  Int Arch Occup Environ Health       Date:  2007-01-12       Impact factor: 2.851

9.  Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy.

Authors:  Koichi Inoue; Fumio Okada; Rie Ito; Shizue Kato; Seiko Sasaki; Sonomi Nakajima; Akiko Uno; Yasuaki Saijo; Fumihiro Sata; Yoshihiro Yoshimura; Reiko Kishi; Hiroyuki Nakazawa
Journal:  Environ Health Perspect       Date:  2004-08       Impact factor: 9.031

10.  Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers.

Authors:  Geary W Olsen; Jean M Burris; David J Ehresman; John W Froehlich; Andrew M Seacat; John L Butenhoff; Larry R Zobel
Journal:  Environ Health Perspect       Date:  2007-09       Impact factor: 9.031

View more
  3 in total

1.  Perfluoroalkyl substances and beta cell deficient diabetes.

Authors:  Baqiyyah Conway; Karen E Innes; Dustin Long
Journal:  J Diabetes Complications       Date:  2016-05-04       Impact factor: 2.852

2.  Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes.

Authors:  Baqiyyah N Conway; Ashley N Badders; Tina Costacou; John M Arthur; Kim E Innes
Journal:  Diabetes Metab Syndr Obes       Date:  2018-11-15       Impact factor: 3.168

3.  Perfluoroalkyl substances and likelihood of stroke in persons with and without diabetes.

Authors:  Robert Hutcheson; Kim Innes; Baqiyyah Conway
Journal:  Diab Vasc Dis Res       Date:  2019-12-16       Impact factor: 3.291

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.